Stage IIIB Lung Cancer AJCC v8

Explore clinical trials studying Stage IIIB Lung Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

57 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Stage IIIB Lung Cancer AJCC v8 trial results

Active, Not Recruiting

Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer

NCT04013542

Conditions: ALK Gene Rearrangement, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

NCT04428905

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +38 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

NCT03830918

Conditions: Advanced Malignant Solid Neoplasm, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer

NCT05340309

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

A Nurse-Led Intervention for Fear of Progression in Advanced Cancer

NCT04819997

Conditions: Advanced Lung Carcinoma, Lung Diseases, Lung Neoplasms, +13 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

NCT02955290

Conditions: Advanced Head and Neck Squamous Cell Carcinoma, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +29 more
Locations: Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

Roswell Park Cancer Institute Buffalo, New York, United States

St. Francis Hospital Roslyn, New York, United States

Good Samaritan Hospital West Islip, New York, United States

View Trial Details

Active, Not Recruiting

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

NCT02983578

Conditions: Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, +46 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Stage IIIB Lung Cancer AJCC v8

Stage IIIB Lung Cancer AJCC v8 trial results

Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer

A Nurse-Led Intervention for Fear of Progression in Advanced Cancer

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

Related conditions